1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLC22A18 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA LGR5 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA ANXA7 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA CHMP4C CTRPv2 pan-cancer AAC 0.11 0.01
mRNA DLEC1 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA SNX20 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA UBALD1 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA GOLGA3 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA KLHL6 CTRPv2 pan-cancer AAC -0.12 0.01
mRNA TAS2R9 CTRPv2 pan-cancer AAC 0.091 0.01
Download CSV